Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
Condition(s):NeuroblastomaLast Updated:September 24, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):NeuroblastomaLast Updated:September 24, 2020Terminated
Condition(s):LymphomaLast Updated:September 18, 2023Active, not recruiting
Condition(s):Alzheimers DiseaseLast Updated:August 5, 2021Terminated
Condition(s):B Cell Lymphoma; Acute Lymphoblastic Leukemia, Pediatric; LymphomaLast Updated:February 12, 2024Active, not recruiting
Condition(s):Pancreatic CancerLast Updated:November 6, 2007Suspended
Condition(s):Solid CancerLast Updated:May 16, 2013Completed
Condition(s):Cytomegalovirus (CMV); Kidney Disease; Kidney FailureLast Updated:March 8, 2024Not yet recruiting
Condition(s):Prostate CancerLast Updated:May 26, 2021Terminated
Condition(s):Multiple MyelomaLast Updated:May 6, 2008Completed
Condition(s):Neoplasms; Carcinoma, Squamous; Antineoplastic AgentsLast Updated:July 27, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.